10/30/2025
Alnylam Stock Has Already Doubled In 2025. But It Took A Hit On Earnings.
The company said Thursday it has received a subpoena from the U.S. government over how it prices its four drugs.
Empowering investors since 1984.
Los Angeles, CA
Be the first to know and let us send you an email when Investor's Business Daily posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Investor’s Business Daily provides proprietary stock screens, comparative performance ratings, and unique commentary helping investors zero in on top-performing growth stocks. IBD provides the buy rules and sell rules to properly make trading decisions that will minimize your risk and maximize your potential profit. IBD offers individual and professional investors a comprehensive lineup of print and online products, all based on a powerful investing system that has dramatically outperformed the S&P 500. Learn more about IBD and start your investing journey HERE.